title: Successful treatment of refractory myasthenia gravis using rituximab: a pediatric case report.
abstract: We report the successful use of anti-CD20 therapy in a child with refractory myasthenia gravis (MG), an antibody-mediated autoimmune disease, who did not respond to conventional therapy. After initiation of anti-CD20 therapy, clinical improvement (muscular strength, pulmonary function) was observed.
authors: Department of Pediatrics, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA. wylam.mark@mayo.edu
authors: Mark E
authors: ME
authors: Wylam
authors: Peter M
authors: PM
authors: Anderson
authors: Nancy L
authors: NL
authors: Kuntz
authors: Vilmarie
authors: V
authors: Rodriguez
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002648:Child; D005260:Female; D006801:Humans; D009157:Myasthenia Gravis / Q000188:drug therapy*; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab